WHWK - Aadi Bioscience Quarterly EPS earnings growth

Aadi Bioscience (WHWK) - corporate logo

The current quarterly EPS rate demonstrates yield dynamics, where 12.10 reflects the latest metric value. Aadi Bioscience Inc (WHWK) is building a precision oncology ecosystem by linking clinics through exclusive supplies of the drug Fyarro. A team of elite scientists is retained by the prestige of working with mTOR inhibitors. The autonomous commercialization cycle of targeted therapy protects the company's revenue from global economic downturns.

aadibio.com (WHWK) - Quarterly EPS earnings growth from 03/20/2025 to 11/12/2026

Comprehensive metric breakdowns and analytics for Aadi Bioscience Inc (WHWK)

- market value and analyst target forecast:
Price Chart aadibio.com|WHWK - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Aadi Bio|WHWK - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Aadi Bioscience|WHWK - Book Capitalization|Market Capitalization to Book Value Ratio aadibio.com|WHWK - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Aadi Bioscience Inc|WHWK - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital aadibio.com|WHWK - Company Total Debt Obligations|Debt to Book Value Aadi Bio|WHWK - Company Long-Term Loans and Borrowings|Company Short-Term Debts Aadi Bioscience|Quick Ratio aadibio.com
- earnings and valuation multiples indicators:
WHWK - Net Financial Result|Expected Profit Aadi Bioscience Inc|WHWK - Market Cap to Earnings|Future Price to Earnings aadibio.com|WHWK - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Aadi Bio|WHWK - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Aadi Bioscience|WHWK - Net earnings per share for the last four quarters|Quarterly EPS earnings growth aadibio.com|WHWK - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Aadi Bioscience Inc
Analysis of all company metrics:Aadi Bioscience, Inc., WHWK
Flagship merchandise of Aadi Bioscience Inc

Sales of the drug Fyarro form the foundation of Aadi Bioscience Inc (WHWK) cash flow, determining the company's ability to generate real profit. This trend is reflected in the calculation of the percentage change in quarterly net income per share, which allows the current quarterly EPS growth rate to separate fundamental growth from market volatility and assess the risk of overpaying for the asset.

Who Aadi Bioscience Inc competes with

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth urogen.com (URGN)|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|Quarterly EPS earnings growth Personalis Inc PSNL|Erasca Corp - Quarterly EPS earnings growth|DCTH (Delcath Corp) - Year-over-year earnings per share growth for the last 12 months|YMAB: Quarterly EPS earnings growth|AURA - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CADL|ARAY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SLS|Year-over-year earnings per share growth for the last twelve months ACTU (Actuate Therapeutics Inc)|Quarterly EPS earnings growth CTOR (Citius Oncology, Inc.)|Year-over-year net earnings per share change for the last twelve months TuHURA Biosciences Inc. (HURA)|TARA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Fate Therapeutics Inc|tscan.com (TCRX) - Year-over-year earnings per share growth for the last twelve months|CSBR - Year-over-year net earnings per share change for the last twelve months|XBIT (XBiotech Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months CEL-SCI Corp (CVM)|Quarterly EPS earnings growth OSTX|Year-over-year net earnings per share change for the last twelve months Radiopharm Theranostics Ltd|Quarterly EPS earnings growth ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd (ANL) - Earnings per share growth in annualized terms for the last twelve months|VERU - Year-over-year earnings per share growth for the last twelve months|TPST (tempesttx.com) - Year-over-year earnings per share growth for the last 12 months|XLO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Renovaro|MURA (Mural Oncology PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Kairos Pharma Inc KAPA|Year-over-year net earnings per share growth for the last 12 months OKUR (OnKure Therapeutics Inc)|GDTC (w2.cytomed.sg) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CRIS (Curis)|Year-over-year net earnings per share change for the last twelve months Apollomics Inc. (APLM)|THAR - Year-over-year earnings per share growth for the last twelve months|ADVB (Advanced Biomed Inc) - Year-over-year earnings per share growth for the last 12 months|GNPX: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Calidi Biotherapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months SBFM|Year-over-year net earnings per share growth for the last 12 months Xenetic Bio (XBIO)|Quarterly EPS earnings growth SLRX|PPBT (Kitov Pharma) - Year-over-year earnings per one share growth for the last 12 months|American Oncology Network, Inc. - Year-over-year net earnings per share growth for the last 12 months|BGNE - Year-over-year net earnings per share growth for the last 12 months|CKPT - Year-over-year earnings per share growth for the last twelve months|ELEV - Quarterly EPS earnings growth|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology|NTBL (Notable Labs, Ltd.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Viracta|Year-over-year earnings per share growth for the last twelve months MorphoSys (MOR)|NAYA Biosciences Inc - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage Pharma Group Ltd)